Baxter International Inc. (BAX) – Market Performance Update
Price Movement Baxter shares closed down 1.92 % during the 24‑hour period ending 01:16 PM Central Europe on Wednesday 21 March 2026. The current trading price is USD 24.51 per share on major exchanges.
Trading Volume and Market Capitalisation In the last 24 hours, approximately USD 298.6 million worth of Baxter shares were traded. Total shares outstanding: 517 million. Market capitalisation: USD 12.9 billion.
Historical Performance Since the end of the previous month, Baxter’s share price has risen 6.89 %. 52‑week high: USD 30.00 (recorded 30 July 2026). 52‑week low: USD 15.73 (recorded 30 March 2026). The 200‑day simple moving average is USD 21.16.
Peer Performance (Last 24 Hours)
| Ticker | Company | Price Change | Current Price | Market Capitalisation | P/E Ratio | Additional Notes |
|---|---|---|---|---|---|---|
| BSP | Bending Spoons Spa | –0.22 % | USD 45.55 | USD 14.8 bn | 197.5 | – |
| LSCC | Lattice Semiconductor | –1.21 % | USD 107.41 | USD 15.4 bn | 429.42 | Recent rally raised concerns about overvaluation. Analysts discuss whether gains reflect fundamental shifts or temporary market enthusiasm. |
| W | Wayfair | +1.41 % | USD 113.56 | USD 15.3 bn | – | – |
| MTZ | Mastec | –1.87 % | USD 187.34 | USD 15.1 bn | 30.12 | – |
Corporate Governance Notice
- Barkly Rare Earths Limited will hold its annual general meeting on 27 November 2026 at the Subiaco Business Centre. Shareholders will consider the annual financial report, remuneration report, and several resolutions, including:
- Adoption of the remuneration report.
- Election and re‑election of directors.
- Ratification of a recent options issue.
- Approval of a new equity‑issuance mandate. The agenda reflects standard corporate governance practices for a listed mining company and aims to support board composition and future financing flexibility.
Company Overview – Baxter International Inc.
- Industry: Healthcare
- Headquarters: Deerfield, United States
- Business Focus: Development, manufacturing, and marketing of products and technologies for conditions such as hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute conditions.
- Customer Base: Hospitals, kidney dialysis centres, nursing homes, rehabilitation centres, doctors’ offices, and research laboratories.
- Listing: New York Stock Exchange (NYSE).
- Website: www.baxter.com
All figures are based on publicly available market data as of the specified date and time. No investment advice is provided.
